OQROGet OQRO Pro
Insider trade

Quest Diagnostics (DGX)Officer sold ~$2.09M

Catherine T. Doherty, Officer at Quest Diagnostics, sold ~$2.09M of Quest Diagnostics shares.

~$2.09M
Approx. value · 10K sh @ $206.37
74K
Holds after · shares reported
Traded
Feb 13, 2026
Filed
Feb 17, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Apr 28, 2025CongressDisclosed purchase of DGX — reported range $1,001 - $15,000
  2. Jul 24, 2025CongressDisclosed sale of DGX — reported range $1,001 - $15,000
  3. Jan 12, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  4. Feb 10, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  5. Feb 10, 2026InsiderOfficer sold ~$1.16M of DGX shares in the open market
  6. Feb 13, 2026 · this disclosureInsiderOfficer sold ~$2.09M of DGX shares in the open market

What came next

  1. Feb 13, 2026Insider · 1 personInsiders: 4 sales (~$3.3M)
  2. Feb 19, 2026Insider · 3 peopleInsiders: 3 sales (~$717K)
  3. Mar 2, 2026InsiderCEO sold ~$2.13M of DGX shares in the open market
  4. Mar 3, 2026Insider · 3 peopleInsiders: 3 sales (~$326K)
  5. Mar 4, 2026InsiderOfficer sold ~$538K of DGX shares in the open market
  6. Mar 5, 2026Insider · 3 peopleInsiders: 3 sales (~$2.5M)
  7. Mar 9, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On March 9, 2026, the Board of Directors (the “Board”) of Quest Diagnostics Incorporated (the “Company”), after considering the recommendation of the Board's Governance Committee, elected Timothy Wentworth, former chief executive officer of Walgreens Boots Alliance, as a director.”
  8. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  9. Apr 1, 2026Federal contract · $3.1M obligatedDepartment of Veterans Affairs awarded Quest Diagnostics: $3.12M obligated to date
  10. Apr 2, 2026Federal contract · $2.7M obligatedDepartment of Veterans Affairs awarded Quest Diagnostics: $2.71M obligated to date
  11. Apr 21, 2026Company filing · Form 8-K · ResultsReported its results
  12. Apr 29, 20265% stakeVanguard Portfolio Management reported a passive stake (13G) of 5.5%
  13. Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
  14. May 1, 2026Federal contract · $2.6M obligatedDepartment of Veterans Affairs awarded Quest Diagnostics: $2.6M obligated to date
  15. May 6, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
  16. Jun 1, 2026InsiderCEO sold ~$1.94M of DGX shares in the open market
  17. Jun 4, 2026Insider · Their largest sale since 2024Officer sold ~$1.63M of DGX shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Quest Diagnostics

For Quest Diagnostics, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 5 Congress trade reports, 12 fund holdings reports (13F) and 7 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DGX page.

Other recent filings by Catherine T. Doherty, EVP, Regional Businesses

The full history of Catherine T. Doherty, EVP, Regional Businesses is on the profile page.

How this filing works

Other disclosures at Quest Diagnostics

Everything OQRO holds on this company is on its DGX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data